Clinical features and volumetric quantifications of the study patients
| Patient . | Age (yr) . | Gender . | Neurological disease . | Medication . | TIV (mm3) . | Normalized MLV volume . | Normalized venous volume . |
|---|---|---|---|---|---|---|---|
| 1 | 64 | F | IIH + CSF leak | 1,414,960 | 3,770.45 | 19,190.93 | |
| 2 | 73 | F | IIH + CSF leak | 1,397,400 | 3,429.09 | 13,044.44 | |
| 3 | 49 | F | IIH | Acetazolamide | 1,158,840 | 2,474.28 | 10,802.18 |
| 4 | 40 | F | IIH | Acetazolamide | 1,273,760 | 2,579.78 | 13,746.00 |
| 5 | 25 | F | IIH | Acetazolamide | 1,270,220 | 2,479.75 | 14,631.01 |
| 6 | 42 | M | JS | 1,432,380 | 7,500.31 | 10,156.52 | |
| 7 | 27 | M | MS with acute demyelinating event | Tecfidera 480 mg; methylprednisolone (3 g) <10 d | 1,546,820 | 7,372.09 | 13,081.61 |
| 8 | 38 | F | MS with acute demyelinating event | Methylprednisolone (3 g) <10 d | 1,094,560 | 2,786.73 | 10,692.70 |
| 9 | 54 | F | MS | 1,312,850 | 3,142.83 | 16,197.20 | |
| 10 | 67 | M | MS | Dimethyl fumarate (14 mg) | 1,464,580 | 7,703.16 | 22,947.60 |
| 11 | 37 | M | GSD | 1,382,580 | 15,470.42 | 20,718.80 | |
| Mean (SEM) | 47 (4.82) | 4:7 (M:F) | 1,340,814 (40,519.6) | 5,337.17 (1,200.30) | 15,019.00 (1,292.32) |
| Patient . | Age (yr) . | Gender . | Neurological disease . | Medication . | TIV (mm3) . | Normalized MLV volume . | Normalized venous volume . |
|---|---|---|---|---|---|---|---|
| 1 | 64 | F | IIH + CSF leak | 1,414,960 | 3,770.45 | 19,190.93 | |
| 2 | 73 | F | IIH + CSF leak | 1,397,400 | 3,429.09 | 13,044.44 | |
| 3 | 49 | F | IIH | Acetazolamide | 1,158,840 | 2,474.28 | 10,802.18 |
| 4 | 40 | F | IIH | Acetazolamide | 1,273,760 | 2,579.78 | 13,746.00 |
| 5 | 25 | F | IIH | Acetazolamide | 1,270,220 | 2,479.75 | 14,631.01 |
| 6 | 42 | M | JS | 1,432,380 | 7,500.31 | 10,156.52 | |
| 7 | 27 | M | MS with acute demyelinating event | Tecfidera 480 mg; methylprednisolone (3 g) <10 d | 1,546,820 | 7,372.09 | 13,081.61 |
| 8 | 38 | F | MS with acute demyelinating event | Methylprednisolone (3 g) <10 d | 1,094,560 | 2,786.73 | 10,692.70 |
| 9 | 54 | F | MS | 1,312,850 | 3,142.83 | 16,197.20 | |
| 10 | 67 | M | MS | Dimethyl fumarate (14 mg) | 1,464,580 | 7,703.16 | 22,947.60 |
| 11 | 37 | M | GSD | 1,382,580 | 15,470.42 | 20,718.80 | |
| Mean (SEM) | 47 (4.82) | 4:7 (M:F) | 1,340,814 (40,519.6) | 5,337.17 (1,200.30) | 15,019.00 (1,292.32) |
F, female; M, male. The volumes of MLVs and venous sinuses were normalized against the TIV.